Related content

The role of radical prostatectomy in patients with pretreatment prostate-specific antigen >=40 ng/mL*

By Vanasupa B.P.   Paquette E.L.   Wu H.   Sun L.   McLeod D.G.   Moul J.W.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 4, 2002-07 ,pp. : 167-172

Elsevier

Access to resources Recommend Favorite

Continuous prostate-specific antigen rise despite salvage radiotherapy following radical prostatectomy: Pattern of clinical relapse and predictive factors

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1138-1142

Spandidos Publications

Access to resources Recommend Favorite

Kinetics of Prostate-specific Antigen After Manipulation of the Prostate

By Bossens M.M.F.   Van Straalen J.P.   De Reijke T.M.   Kurth K.H.   Sanders G.T.B.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 682-685

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen kinetics after failure of primary prostate cancer therapy: a valuable prognostic factor

By Pickles Tom  

Future Oncology, Vol. 3, Iss. 4, 2007-08 ,pp. : 393-395

Future Medicine

Access to resources Recommend Favorite

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

By Kupelian P.A.   Elshaikh M.   Reddy C.A.   Zippe C.   Klein E.A.   Ritter M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 308-309

Elsevier

Access to resources Recommend Favorite